title: Prostate specific antigen levels following transurethral resection of the prostate.
abstract: OBJECTIVE
  Determine how serum prostate-specific antigen (t-PSA) levels and free PSA (f/t PSA) ratio change following transurethral resection of the prostate (TURP).
  
  
  METHODS
  Thirty men with a mean age of 67.0 +/- 4.2 years (range 46 to 84 years) underwent TURP for BPH between May 2005 and October 2005. Preoperative assessment included symptom evaluation with the International Prostate Symptom Score (I-PSS) and the prostate volume estimation by transrectal ultrasound. Total PSA and f/t PSA ratio were assessed before the procedure, as well as 30, 60 and 180 days after the TURP.
  
  
  RESULTS
  Clinical improvement after TURP, reflected by I-PSS score, was demonstrated as early as 30 days and remained stable until the end of the follow-up. Mean t-PSA declined 71% after TURP and 60 days after surgery the reduction reached its peak, stabilizing afterwards. It varied from 6.19 +/- 7.06 ng/mL before surgery to 1.75 +/- 1.66 ng/mL on day 60 (p < 0.001). The mean baseline f/t PSA ratio was 18.2% +/- 3.4% and was not significantly changed at any given time point in the postoperative period (p = 0.91). There were also no statistically significant differences in t-PSA or f/t PSA between patients with and without prostatitis at any time point (p = 0.23). Resected prostate fragments weighed 29.9 +/- 19.6 g, corresponding to 39.1% of the estimated preoperative prostate volume. Each gram of tissue resected decreased PSA by 0.15 +/- 0.11 ng/mL, while 1% prostate volume resected led to a reduction of 2.4% +/- 0.4% in serum PSA from baseline.
  
  
  CONCLUSIONS
  PSA decreases drastically in patients who undergo TURP. These low levels stabilize within 60 days after surgery. The f/t PSA ratio did not change, and the finding of chronic prostatitis did not affect the levels of these variables.
authors.affiliation: Division of Urology, University of Sao Paulo School of Medicine, Sao Paulo, Brazil.
authors.forename: Roberto C
authors.initials: RC
authors.lastname: Fonseca
authors.forename: Cristiano M
authors.initials: CM
authors.lastname: Gomes
authors.forename: Elton B
authors.initials: EB
authors.lastname: Meireles
authors.forename: Geraldo C
authors.initials: GC
authors.lastname: Freire
authors.forename: Miguel
authors.initials: M
authors.lastname: Srougi
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000704:Analysis of Variance; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D011184:Postoperative Period; D011300:Preoperative Care; D011446:Prospective Studies; D017430:Prostate-Specific Antigen / Q000097:blood*; D011470:Prostatic Hyperplasia / Q000097:blood / Q000175:diagnosis / Q000601:surgery*; D020728:Transurethral Resection of Prostate
chemical_list: D017430:Prostate-Specific Antigen